Loading institutional data...
Loading institutional data...
Institutional ownership roughly stable: +0.15% change quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Ranked against 1111 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | $1.05T | 51.0× | — | 16.1× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $679.0B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $620.1B | 23.4× | — | 6.6× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $435.4B | 104.3× | 31.4× | 7.1× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| UNH | $374.0B | 31.2× | 21.4× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| BDRX | $359.1B | — | — | — | — | — | — | — | — | — | 7 |
| MRK | $321.1B | 17.6× | — | 4.9× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| NVSEF | $289.9B | — | — | — | — | — | — | — | — | — | 2 |
| AZN | $250.4B | — | — | — | — | — | — | — | — | — | 1,248 |
| AMGN | $219.7B | 28.7× | 18.3× | 6.0× | 10.0% | 67.2% | 21.0% | 89.1% | 13.1% | 3.5× | 3,014 |
| TMO | $217.8B | 32.6× | 28.5× | 4.9× | 3.9% | — | 15.1% | 12.6% | 7.0% | 4.9× | 2,481 |
| ABT | $183.9B | 28.4× | 19.5× | 4.2× | 5.7% | 56.4% | 14.7% | 12.5% | 10.5% | 1.0× | 2,964 |
| GILD | $163.5B | 19.4× | 18.1× | 5.5× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| PFE | $146.7B | 19.0× | — | 2.3× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $141.1B | 39.5× | 29.3× | 5.7× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $133.2B | 47.7× | 36.6× | 13.2× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| SYK | $128.8B | 40.1× | 21.8× | 5.1× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| CVS | $126.0B | 71.3× | 12.7× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| VRTX | $123.1B | 31.6× | 26.9× | 10.3× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| MDT | $110.1B | 23.1× | 11.7× | 3.0× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| GLAXF | $106.9B | — | — | — | — | — | — | — | — | — | 5 |
| MCK | $102.7B | 22.9× | 16.2× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| SNYNF | $101.3B | — | — | — | — | — | — | — | — | — | 5 |
| HCA | $92.0B | 14.5× | — | 1.2× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $86.4B | 15.5× | 14.8× | 0.4× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| SCNX | $16M | — | — | 36.6× | 216% | 76.8% | -9618% | -59.2% | -59.2% | — | 14 |
Peers = companies sharing SCNX's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 14 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -59%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $7M covers all $666516 of scheduled principal — no refinancing pressure. Scheduled principal only (excludes interest & revolver draws). As of 2017-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest.
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-08-05 · 15d old
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $432K 100.0% | $137K 100.0% | $1.4M 100.0% | $10.3M 100.0% | $9.9M 100.0% | $17.1M 100.0% | $7.4M 100.0% | $3.8M 100.0% | $2.9M 100.0% | $2.5M 100.0% |
| Cost of Revenue | $100K 23.2% | $131K 95.6% | $1.3M 96.4% | $4.7M 46.2% | $5.1M 52.0% | $11.4M 66.7% | $2.6M 34.5% | $449K 11.7% | — | $16K 0.7% |
| Cost of Products | — | — | — | — | — | — | — | — | — | $16K 0.7% |
| Gross Profit | $331K 76.8% | $6K 4.4% | $49K 3.6% | $5.5M 53.8% | $4.7M 48.0% | $5.7M 33.3% | $4.9M 65.5% | $3.4M 88.3% | $2.9M 100.0% | $2.5M 100.0% |
| Research & Development | $2.0M 453.3% | $2.2M 1636.9% | — | — | — | — | — | — | — | — |
| Selling, General & Admin | $7.9M 1836.4% | $6.7M 4886.9% | $1.3M 98.0% | $1.7M 16.5% | $1.9M 19.2% | $7.5M 43.7% | $4.4M 58.9% | $3.5M 90.6% | $2.5M 86.5% | $3.5M 140.6% |
| Total Operating Expenses | $42.9M 9944.7% | $14.7M 10763.1% | $4.4M 326.0% | $8.4M 82.3% | $10.0M 101.5% | $8.2M 48.0% | $4.7M 63.8% | $3.5M 90.6% | — | — |
| Operating Income | -$42.6M -9867.9% | -$14.7M -10758.7% | -$4.4M -322.4% | -$2.9M -28.4% | -$5.3M -53.5% | -$2.5M -14.6% | $125K 1.7% | -$88K -2.3% | $395K 13.5% | -$1.0M -40.6% |
| Interest Expense | $4.1M 946.0% | $1.3M 977.5% | $1.2M 87.9% | $336K 3.3% | $24K 0.2% | $29K 0.2% | $53K 0.7% | $58K 1.5% | $157K 5.4% | $152K 6.1% |
| Interest & Investment Income | $303K 70.1% | $135K 99.0% | $4K 0.3% | $21K 0.2% | — | — | — | — | — | — |
| Other Income (Expense), net | -$916K -212.3% | -$4.1M -2984.3% | -$4.1M -299.6% | $513K 5.0% | -$24K -0.2% | — | — | — | — | — |
| Pretax Income | -$43.5M -10080.2% | -$18.8M -13743.0% | -$8.5M -622.0% | — | — | — | — | — | — | — |
| Income Tax Expense | -$2.0M -462.2% | -$534K -391.1% | — | — | — | — | — | — | — | — |
| Net Income | -$41.5M -9618.0% | $9.1M 6634.7% | -$17.8M -1308.3% | -$3.5M -33.9% | -$5.3M -53.8% | -$2.5M -14.8% | -$284K -3.8% | $9K 0.2% | $289K 9.9% | -$2.8M -111.2% |
| Per Share | ||||||||||
| EPS (Basic) | $-2.70 | $2.69 | $-23.35 | $-6.15 | $-0.65 | — | $-0.05 | $0.00 | $0.01 | $-0.09 |
| EPS (Diluted) | $-2.70 | $2.48 | $-23.35 | $-6.13 | $-0.65 | — | $-0.05 | $0.00 | $0.01 | $-0.09 |
| Weighted Avg Shares (Basic) | 15.3M | 3.4M | 764K | 565K | 8.1M | — | 5.9M | 5.4M | 32.0M | 31.5M |
| Weighted Avg Shares (Diluted) | 15.3M | 3.7M | 2.4M | 567K | — | — | 5.9M | 5.8M | 34.1M | 31.5M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
4/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-08-05
Where each multiple sits in its own 12-yr range · 21th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 12-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 11.7 | 34.5 | 66.7 | 52.0 | 46.2 | 96.4 | 95.6 | 23.2 |
| Gross Profit | 88.3 | 65.5 | 33.3 | 48.0 | 53.8 | 3.6 | 4.4 | 76.8 |
| R&D | — | — | — | — | — | — | 1636.9 | 453.3 |
| SG&A | 90.6 | 58.9 | 43.7 | 19.2 | 16.5 | 98.0 | 4886.9 | 1836.4 |
| Operating Income | -2.3 | 1.7 | -14.6 | -53.5 | -28.4 | -322.4 | -10758.7 | -9867.9 |
| Income Tax | — | — | — | — | — | — | -391.1 | -462.2 |
| Net Income | 0.2 | -3.8 | -14.8 | -53.8 | -33.9 | -1308.3 | 6634.7 | -9618.0 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on SCNX: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.